Welcome to the 11th Annual World ADC San Diego Conference
The 11th World ADC San Diego returns in 2020 bigger and better than before with more speakers, tracks and seminar days. Last year we reflected on what was been a rollercoaster of a decade and finished the year with a total of three approved ADCs on the market. With the recent approval in 2020 and 8 ADCs now on the market, the sky is the limit for ADCs as they have well and truly proven their potential. This year we can learn from these approvals and hear from the leading drug developers pushing to get the next ADC on the market.
With over 100 industry expert speakers sharing detailed presentations over 5 tracks, 5 focused seminar days and 10 interactive workshops, we have added many new elements to ensure we bring you the most cutting-edge content:
- Hear from Daiichi Sankyo, Seattle Genetics and Genentech as they share their journeys to getting their drugs on the market in 2019
- Join Bolt Bio, Mersana and Ambrx on their novel payload types sharing the story of immune-stimulatory ADCS
- Gain an update from Patrick Van Berckel at ADC Therapeutics on Loncastuximab tesirine with overview of the manufacturing strategy, the clinical data and more…
- Learn from Dario Neri the importance of Small molecule-drug conjugates (SMDCs) and ADCs: a comparative evaluation
Join over 600 attendees across four days jam packed days and take advantage of this unrivalled learning and networking opportunity and build the foundation for successful future collaborations.
Complete Your 4-day World ADC Experience
Pre-Conference Seminar Day
Tuesday, September 15
Exploring in-depth the emerging areas of interest and hottest topics in the ADC field, take your pick from 5 pre-conference seminars.
Enjoy a full day of presentations, roundtable sessions and panel discussions that highlight the biggest opportunities in the space and address their unique challenges.
- Introduction to ADCs Day
- 1st Toxicity Day (NEW!)
- 2nd CMC Day
- 4th ADC & Combinations Day
- 5th Analytical & Bioanalytical Day
2 Conference Days: 5 Tracks
Wednesday, September 16
Thursday, September 17
Providing you and your team with the full end-to-end drug development landscape, the two main summit days are divided across 5 comprehensive tracks of learning and delve into the following topics:
- Process Development
Bring your team to divide and conquer, ensuring your whole company can benefit from the full range of world-class expertise being showcased from our 105 expert speakers.
Post-Conference Workshop Day
Friday, September 18
And finally, take those exciting discussions one step further by collaborating in an intimate environment with fellow ADC drug developers who are actively working on the same challenges as you.
Choose from 10 discussion-based, deep-dive workshops, including:
Design, Synthesis & Preclinical Validation of Next Generation Linker & Site-Specific Conjugation
Cancer Drug Delivery Systems Based on the Tumor Microenvironment
Scale Up, Outsourcing & Managing Complex Supply Chains
Don’t miss the chance to ask your specific questions to the topic experts, and leave equipped with the technical knowledge required to bring an antibody drug conjugate to market.
About World ADC Series
The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.